These results provide a translational approach to the study that could be implemented in the future for the benefit of patients, and they pose PI3K/AKT–MDM2–p53 signaling pathway as an essential target for the preconditioning-promoted IT strategies in ischemic stroke. This evidence concerns the gene TP53 and ischemic stroke.